Post-exertional Malaise in People With Chronic Cancer-Related Fatigue.
Twomey, Rosie, Yeung, Samuel T, Wrightson, James G et al. · Journal of pain and symptom management · 2020 · DOI
Quick Summary
This study looked at whether people with long-lasting cancer-related fatigue experience post-exertional malaise (PEM)—a condition where symptoms get worse after physical or mental activity. Researchers asked 18 people with severe, ongoing fatigue to report their experiences over six months and during exercise testing. They found that up to one-third of participants showed signs of PEM, including fatigue that worsened after minimal effort and recovery taking more than 24 hours.
Why It Matters
This study is significant because it provides evidence that post-exertional malaise—a hallmark feature of ME/CFS—may also affect people with chronic cancer-related fatigue, suggesting overlapping pathophysiological mechanisms. Recognition of PEM in cancer survivors could prevent harmful exercise prescriptions and inform better management strategies. The findings highlight the importance of screening for PEM across different fatigue conditions and tailoring rehabilitation approaches accordingly.
Observed Findings
3 of 18 participants (17%) met strict DePaul Symptom Questionnaire-PEM criteria with moderate-to-very severe symptoms occurring at least half the time, worsening fatigue after minimal effort, and recovery >24 hours
5 of 18 participants (28%) reported delayed recovery and PEM-like symptoms following maximal exercise testing via open-ended questionnaire responses
Up to 33% of the sample showed some evidence of post-exertional symptom exacerbation
Participants with chronic cancer-related fatigue scored ≤34 on the Functional Assessment of Chronic Illness Therapy-Fatigue scale, indicating severe functional impairment
Inferred Conclusions
A clinically meaningful subset of people with chronic cancer-related fatigue (up to one-third) may experience post-exertional malaise
Exercise professionals and healthcare providers caring for cancer survivors with chronic fatigue should routinely monitor for symptom exacerbation after activity and adjust exercise prescriptions accordingly to avoid potential harm
The presence of PEM in chronic CRF warrants cautious, individualized, and symptom-limited exercise approaches rather than standard progressive exercise protocols
Remaining Questions
What proportion of the broader cancer survivor population with chronic fatigue experiences PEM, and does prevalence differ by cancer type, treatment received, or time since treatment completion?
What This Study Does Not Prove
This study does not establish that cancer-related fatigue and ME/CFS are the same condition, only that some symptom overlap may exist. The small sample size (n=18) and lack of a control group (healthy controls or ME/CFS comparison group) limit generalizability and prevent definitive conclusions about PEM prevalence or severity. Correlation between exercise and symptom worsening does not establish the underlying biological mechanisms causing PEM.
What are the biological mechanisms underlying PEM in cancer-related fatigue—are they identical to those in ME/CFS, or do cancer survivors have distinct pathophysiology?
How should exercise be optimally tailored for cancer survivors with PEM, and what objective markers (biomarkers, heart rate variability, lactate clearance) could guide safe exercise prescription?
Do cancer survivors with PEM have different outcomes, prognosis, or treatment responses compared to those without PEM?